E.T. Edgell

1.9k citations

48 papers · 1.5k indexed · h-index 23

Impact in

Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
Philosophy top 1%
- Mental Health and Psychiatry

Papers in ⓘ

Psychiatry and Mental health 36
- Schizophrenia research and treatment 27
- Bipolar Disorder and Treatment 16
- Electroconvulsive Therapy Studies 5
Economics and Econometrics 15
- Health Systems, Economic Evaluations, Quality of Life 14

Co-authors: Dennis A. Revicki (6 shared papers)Josep María Haro (13 shared papers)S.H. Hamilton (6 shared papers)Gian Gandhi (7 shared papers)Alan Breier (9 shared papers)Jordi Alonso (4 shared papers)Diego Novick (6 shared papers)Emuella Flood (1 shared paper)
Journals: European Neuropsychopharmacology (11 papers)PharmacoEconomics (6 papers)Acta Psychiatrica Scandinavica (6 papers)Value in Health (4 papers)International Clinical Psychopharmacology (3 papers)
Partner nations: United States United Kingdom Spain

In The Last Decade

E.T. Edgell

46 papers receiving 1.4k citations

Peers

Countries citing papers authored by E.T. Edgell

Since Specialization

Citations

This map shows the geographic impact of E.T. Edgell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.T. Edgell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.T. Edgell more than expected).

Fields of papers citing papers by E.T. Edgell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.T. Edgell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.T. Edgell. The network helps show where E.T. Edgell may publish in the future.

Co-authors

The 25 scholars most cited alongside E.T. Edgell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E.T. Edgell Line = papers co-authored together E.T. Edgell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Costs of Bipolar Disorder PharmacoEconomics ·Leah Kleinman, Ana Lowin, Emuella Flood, Gian Gandhi, E.T. Edgell, Dennis A. Revicki	2003	177
2	Direct and Indirect Costs of Non-Vertebral Fracture Patients with Osteoporosis in the US PharmacoEconomics ·Crystal Pike, Howard G. Birnbaum, M. Schiller, Hari Sharma, Russel Burge, E.T. Edgell	2010	114
3	A review of health-related quality-of-life measures used in end-stage renal disease Clinical Therapeutics ·E.T. Edgell, Stephen Joel Coons, William B. Carter, Joel Kallich, Donna Mapes, Teresa M. Damush, Ron D. Hays	1996	109
4	The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment Acta Psychiatrica Scandinavica ·Josep María Haro, E.T. Edgell, Peter B. Jones, Jordi Alonso, Sandra Gavart, Karl J. Gregor, Pádraig Wright, Martín Knapp, (unknown)	2003	96
5	Effectiveness of antipsychotic treatment for schizophrenia: 6‐month results of the Pan‐European Schizophrenia Outpatient Health Outcomes (SOHO) study Acta Psychiatrica Scandinavica ·Josep María Haro, E.T. Edgell, Diego Novick, Jordi Alonso, Liam Kennedy, Peter B. Jones, M Ratcliffe, Alan Breier, (unknown)	2004	82
6	Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia PharmacoEconomics ·S.H. Hamilton, Dennis A. Revicki, E.T. Edgell, Laura A. Genduso, Gary D. Tollefson	1999	82
7	Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample International Clinical Psychopharmacology ·S.H. Hamilton, E.T. Edgell, Dennis A. Revicki, Alan Breier	2000	77
8	A Rasch model analysis to test the cross‐cultural validity of the EuroQoL‐5D in the Schizophrenia Outpatient Health Outcomes Study Acta Psychiatrica Scandinavica ·Luis Prieto, Diego Novick, José Antonio Sacristán, E.T. Edgell, Jordi Alonso, (unknown)	2003	61
9	Olanzapine vs. other antipsychotics in actual out‐patient settings: six months tolerability results from the European Schizophrenia Out‐patient Health Outcomes study Acta Psychiatrica Scandinavica ·Martin Lambert, Josep María Haro, Diego Novick, E.T. Edgell, Liam Kennedy, M Ratcliffe, Dieter Naber	2004	59
10	Olanzapine versus Risperidone PharmacoEconomics ·E.T. Edgell, Scott W. Andersen, Bryan M. Johnstone, Brian Dulisse, Dennis A. Revicki, Alan Breier	2000	57
11	Classifying Patients by Antipsychotic Adherence Patterns Using Latent Class Analysis: Characteristics of Nonadherent Groups in the California Medicaid (Medi-Cal) Program Value in Health ·Jeonghoon Ahn, Jeffrey S. McCombs, Changun Jung, Tim Croudace, David McDonnell, Haya Ascher‐Svanum, E.T. Edgell, Lizheng Shi	2007	56
12	Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status International Clinical Psychopharmacology ·Lizheng Shi, M. Namjoshi, F. Zhang, Gian Gandhi, E.T. Edgell, Mauricio Tohen, Alan Breier, Josep María Haro	2002	54
13	The European Schizophrenia Outpatient Health Outcomes Study: baseline findings across country and treatment Acta Psychiatrica Scandinavica ·Josep María Haro, E.T. Edgell, Paul Frewer, Jordi Alonso, Peter B. Jones, (unknown)	2003	52
14	Health State Utilities for Childhood Attention-Deficit/Hyperactivity Disorder Based on Parent Preferences in the United Kingdom Medical Decision Making ·Kristina Secnik, Louis S. Matza, Suzi Cottrell, E.T. Edgell, Dominic Tilden, Sally Mannix	2005	52
15	Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study International Clinical Psychopharmacology ·I. Gasquet, Josep María Haro, Diego Novick, E.T. Edgell, Liam Kennedy, J.P. Lépine	2005	44
16	Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States Journal of Medical Economics ·Mallik Angalakuditi, E.T. Edgell, Anthony Beardsworth, Erin Buysman, Tim Bancroft	2010	40
17	Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study) BMC Psychiatry ·Ignacio García‐Cabeza, Juan Carlos Gómez, Jose A Sacristán, E.T. Edgell, Manuel González de Chavez	2001	35
18	Cost and utilization of healthcare services for hip and knee replacement Journal of Medical Economics ·Chris M Kozma, Terra Slaton, Andy Paris, E.T. Edgell	2013	31
19	Frequency of Hospitalisations and Inpatient Care Costs of Manic Episodes PharmacoEconomics ·Marie de Zélicourt, Roland Dardennes, Hélène Verdoux, Gian Gandhi, Babak Khoshnood, E. Chomette, Marie-Laure Papatheodorou, E.T. Edgell, C. Even, Francis Fagnani	2003	27
20	Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US Osteoporosis International ·C Pike, Howard G. Birnbaum, M. Schiller, Elyse Swallow, Russel Burge, E.T. Edgell	2010	26

About E.T. Edgell

E.T. Edgell is a scholar working on Psychiatry and Mental health, Economics and Econometrics, Pharmacology, Social Psychology and Surgery, having authored 48 papers that have together received 1.5k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (27 papers), Bipolar Disorder and Treatment (16 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers), Treatment of Major Depression (9 papers), Mental Health Treatment and Access (6 papers), Electroconvulsive Therapy Studies (5 papers), Hip and Femur Fractures (4 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). The work is most often cited by research in Psychiatry and Mental health (1.0k citations), Philosophy (213 citations), Orthopedics and Sports Medicine (112 citations), Clinical Psychology (260 citations) and Nephrology (87 citations). E.T. Edgell has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Dennis A. Revicki, Josep María Haro, S.H. Hamilton, Gian Gandhi, Alan Breier, Jordi Alonso, Diego Novick, Emuella Flood, Ana Lowin and Leah Kleinman. Their work appears in journals such as European Neuropsychopharmacology, PharmacoEconomics, Acta Psychiatrica Scandinavica, Value in Health and International Clinical Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact